TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21409739

Group type: EXPERIMENTAL
Intervention: Videotaped group drug counseling sessions rated for alliance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Videotaped group drug counseling sessions rated for non-positive learning statements received from counselor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Videotaped group drug counseling sessions rated for participation variables
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Videotaped group drug counseling sessions rated for self-disclosures about the past
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Videotaped group drug counseling sessions rated for group cohesion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Videotaped group drug counseling sessions rated for degree of participation of each group member
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Videotaped group drug counseling sessions rated for positive feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Videotaped group drug counseling sessions rated for negative feedback
Number of subjects: 0
Study: 18242535

Group type: EXPERIMENTAL
Intervention: Isolation of all pulmonary veins (PVs)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Isolation of arrhythmogenic pulmonary veins
Number of subjects: 105
Study: 16813477

Group type: EXPERIMENTAL
Intervention: Supine position pelvic-floor muscle exercises
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Supine and upright position pelvic-floor muscle exercises
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups combined (collapsed data)
Number of subjects: 44
Study: 14519796

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Both DASH and Control diets with reduced sodium intake
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: DASH diet with reduced sodium
Number of subjects: 186
Study: 10741082

Group type: EXPERIMENTAL
Intervention: TIVA (Total Intravenous Anesthesia) using a mixture of propofol (45 ml of 1%) and alfentanil (2,500 micrograms)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Inhalational anesthetic technique (isoflurane/N2O, sufentanil)
Number of subjects: 32
Study: 8767028

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 1414227

Group type: EXPERIMENTAL
Intervention: Withdrawal of phenytoin (PT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (PT not changed)
Number of subjects: 29
Study: 2865615

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate patches
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 0
Study: 28986682

Group type: EXPERIMENTAL
Intervention: PRP fibrin glue pleurodesis
Number of subjects: 52

Group type: COMPARATOR
Intervention: Surgical thoracic duct ligation
Number of subjects: 52
Study: 27325778

Group type: EXPERIMENTAL
Intervention: Increasing instruction time
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General increase in instruction time
Number of subjects: 0
Study: 24639419

Group type: EXPERIMENTAL
Intervention: High-oleic peanuts (HOP)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Conventional peanuts (CVP)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (CT)
Number of subjects: 65
Study: 22218066

Group type: EXPERIMENTAL
Intervention: Polyhexanide-containing cellulose dressing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Polyhexanide swabs
Number of subjects: 30
Study: 20185357

Group type: EXPERIMENTAL
Intervention: Diaphragmatic, deep abdominal and pelvic floor muscle retraining (n = 35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Self‐monitored pelvic floor muscle exercises (Control group, n = 35)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Diaphragmatic, deep abdominal and pelvic floor muscle retraining
Number of subjects: 70

Group type: COMPARATOR
Intervention: Self‐monitored pelvic floor muscle exercises
Number of subjects: 70
Study: 17765364

Group type: EXPERIMENTAL
Intervention: Monounsaturated fat (MUFA) diet (SAFA 8%, MUFA 23%)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saturated fat (SAFA) diet (SAFA 17%, MUFA 15%)
Number of subjects: 11
Study: 15685460

Group type: EXPERIMENTAL
Intervention: Harvesting of the central third of the patellar tendon
Number of subjects: 17
Study: 12433647

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of puerarin injection
Number of subjects: 72

Group type: COMPARATOR
Intervention: Intravenous infusion of anisodamine
Number of subjects: 72
Study: 10234289

Group type: EXPERIMENTAL
Intervention: Clinical practice guidelines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evidence-based recommendations (EBR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Practice guidelines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical practice based on scientific evidence
Number of subjects: 0
Study: 8607174

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 1.5 g twice daily (n=77)
Number of subjects: 150

Group type: COMPARATOR
Intervention: High dose intravenous steroids (IVS) 5 mg/kg for 5 days (n=73)
Number of subjects: 150

Group type: COMPARATOR
Intervention: High dose intravenous steroids (IVS)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 150
Study: 1945993

Group type: EXPERIMENTAL
Intervention: Fenoterol (0.25 mg/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 6784809

Group type: COMPARATOR
Intervention: Enema (Control group: 149 women)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: No enema (Experimental group: 125 women)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Both groups (Enema and No enema)
Number of subjects: 274
Study: 30607677

Group type: EXPERIMENTAL
Intervention: Topical FDX104 4% foam applied twice daily for 5 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle foam (placebo) applied twice daily for 5 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical FDX104 4% foam
Number of subjects: 0
Study: 28376235

Group type: EXPERIMENTAL
Intervention: CEAwatch protocol
Number of subjects: 238

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Detection by CEA measurement
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Detection by CT
Number of subjects: 238
Study: 25964400

Group type: EXPERIMENTAL
Intervention: Repeated PPD screening at 6 and 12 months postpartum
Number of subjects: 1432
Study: 23375786

Group type: EXPERIMENTAL
Intervention: LIPUS (14 osteotomies)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (13 osteotomies)
Number of subjects: 27
Study: 21175277

Group type: EXPERIMENTAL
Intervention: Software recommendations for insulin dosage adjustments
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy titrated every 1-4 weeks
Number of subjects: 26
Study: 19837741

Group type: EXPERIMENTAL
Intervention: Nurse led intensive care follow‐up programmes
Number of subjects: 286

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 286
Study: 18300511

Group type: EXPERIMENTAL
Intervention: Capsule YD
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (routine methods)
Number of subjects: 63
Study: 15281518

Group type: EXPERIMENTAL
Intervention: isobaric clonidine (150 microg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: hyperbaric clonidine (150 microg)
Number of subjects: 30
Study: 11497396

Group type: EXPERIMENTAL
Intervention: lenograstim (2 microg/kg daily, s.c.)
Number of subjects: 139

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 139
Study: 9613651

Group type: EXPERIMENTAL
Intervention: Tetravalent rhesus rotavirus vaccine (RV‐TV)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Dose 1 of RV‐TV
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Dose 2 of RV‐TV
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Dose 3 of RV‐TV
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Plaque purification and serotyping after Dose 1
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Plaque purification and serotyping after Dose 2
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Plaque purification and serotyping after Dose 3
Number of subjects: 248
Study: 8021329

Group type: EXPERIMENTAL
Intervention: Fixed-dose transdermal nicotine (21 or 22 mg/day for 6 weeks)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Tapered-dose transdermal nicotine (21 or 22 mg/day for 4 weeks, 14 mg/day for 4 weeks, 7 mg/day for 4 weeks)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Buspirone (5 mg TID for 7 days, then 10 mg TID for 21 days)
Number of subjects: 208
Study: 2563951

Group type: EXPERIMENTAL
Intervention: Coated mesalazine (Mesasal) 1.5 g daily
Number of subjects: 220

Group type: COMPARATOR
Intervention: Sulphasalazine 3.0 g daily
Number of subjects: 220
Study: 31492505

Group type: EXPERIMENTAL
Intervention: Edoxaban (60 mg once daily) plus a P2Y12 inhibitor for 12 months
Number of subjects: 1506

Group type: COMPARATOR
Intervention: Vitamin K antagonist (VKA) in combination with a P2Y12 inhibitor and aspirin (100 mg once daily, for 1-12 months)
Number of subjects: 1506
Study: 29733106

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 82
Study: 26541729

Group type: EXPERIMENTAL
Intervention: Laparoscopic TEP with lightweight PPM
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bilateral repair
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Larger mesh
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Smaller mesh and unilateral repairs
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Laparoscopic TEP
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: General health
Number of subjects: 48
Study: 24787143

Group type: EXPERIMENTAL
Intervention: Vortioxetine 10 mg/d
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Vortioxetine 20 mg/d
Number of subjects: 602

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 602
Study: 22318383

Group type: EXPERIMENTAL
Intervention: Topical 0.1% tretinoin
Number of subjects: 1131

Group type: COMPARATOR
Intervention: Matching vehicle control
Number of subjects: 1131
Study: 20414864

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy by endoscopists with low activity volume (< 85 sigmoidoscopies/year)
Number of subjects: 13764

Group type: EXPERIMENTAL
Intervention: Endoscopists with a lower rate of incomplete sigmoidoscopy (< 9 %)
Number of subjects: 13764

Group type: EXPERIMENTAL
Intervention: Endoscopists with a higher rate of incomplete sigmoidoscopy (> 12 %)
Number of subjects: 13764

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 13764

Group type: EXPERIMENTAL
Intervention: Self-report of one first-degree relative with colorectal cancer (CRC)
Number of subjects: 13764

Group type: EXPERIMENTAL
Intervention: Self-report of recent-onset rectal bleeding
Number of subjects: 13764
Study: 18583869

Group type: EXPERIMENTAL
Intervention: Intracoronary shunt
Number of subjects: 40

Group type: COMPARATOR
Intervention: Soft snare occlusion
Number of subjects: 40
Study: 16055161

Group type: EXPERIMENTAL
Intervention: A‐linked proanthocyanidins from cranberry juice cocktail at 60 microg/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: B‐type proanthocyanidins from grape at 1200 microg/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other B‐type proanthocyanidins from commercial products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cranberry juice cocktail consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-cranberry food products consumption
Number of subjects: 0
Study: 11736673

Group type: EXPERIMENTAL
Intervention: Propofol (2 mg kg(‐1) with fentanyl 100 microg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Halothane (with fentanyl 100 microg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Group 1 (Propofol)
Number of subjects: 30
Study: 9225827

Group type: EXPERIMENTAL
Intervention: Ethanol (0.52 g/kg during 2 hours and 0.3 g/kg during 3 hours)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ethanol (0.69 g/kg during 2 hours and 0.3 g/kg during 3 hours)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ethanol (higher dose)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ethanol (both studies)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 8
Study: 8352178

Group type: EXPERIMENTAL
Intervention: t‐PA
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 3626897

Group type: EXPERIMENTAL
Intervention: Multiple Choice Test (MCQ)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Directed Free Response
Number of subjects: 36

Group type: COMPARATOR
Intervention: Random Context
Number of subjects: 36
Study: 2585237

Group type: EXPERIMENTAL
Intervention: Intravenously administered immune globulin (IVIG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Not applicable (non-randomized group)
Number of subjects: 200
Study: 31112737

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 54
Study: 27862898

Group type: EXPERIMENTAL
Intervention: Desmopressin orally disintegrating tablet (ODT; 10-100 μg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimum effective dose of desmopressin (25 μg in women, 50 μg in men) with a sodium monitoring plan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26365758

Group type: EXPERIMENTAL
Intervention: Current rhinitis
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Rhinitis severity
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Atopic rhinitis
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Rhinitis symptom severity
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Improved asthma control
Number of subjects: 218
Study: 24084400

Group type: EXPERIMENTAL
Intervention: Active intervention (group-based, peer-delivered physical activity intervention)
Number of subjects: 34
Study: 21654683

Group type: EXPERIMENTAL
Intervention: PEP Intervention
Number of subjects: 867

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 867

Group type: COMPARATOR
Intervention: Booklet alone
Number of subjects: 867
Study: 20023357

Group type: EXPERIMENTAL
Intervention: Hyaluronan (Hylan G‐F 20)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (physiological saline)
Number of subjects: 63
Study: 16911176

Group type: EXPERIMENTAL
Intervention: Life skills training (LST) program
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control group (tobacco and drug education curriculum)
Number of subjects: 170
Study: 16209203

Group type: COMPARATOR
Intervention: Routine medication (antibiotic, indomethacin, alpha1 receptor blocker and Chinese traditional medicine)
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Routine medication plus psychologic treatment
Number of subjects: 346
Study: 11318296

Group type: EXPERIMENTAL
Intervention: Tonopen XL
Number of subjects: 104

Group type: COMPARATOR
Intervention: Goldmann tonometer
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Goldmann tonometer and Tonopen XL
Number of subjects: 104
Study: 9644786

Group type: EXPERIMENTAL
Intervention: Epirubicin (EPI) 20 mg/40 ml
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Epirubicin (EPI) 50 mg/100 ml
Number of subjects: 10
Study: 7942792

Group type: EXPERIMENTAL
Intervention: B-CLL cells
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal lymphocytes
Number of subjects: 16
Study: 3366160

Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (5 mg i.v.)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 30
Study: 31487739

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil (50 mg, i.v.)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Intralipid (0.1 mL/kg, i.v.)
Number of subjects: 68
Study: 30640362

Group type: EXPERIMENTAL
Intervention: Exenatide 2 mg once weekly for 48 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 28667201

Group type: EXPERIMENTAL
Intervention: Cognitive processing therapy (CPT) in conjunction with treatment as usual (mostly pharmacotherapy and clinical monitoring)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Treatment as usual alone
Number of subjects: 58
Study: 25451583

Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resistance exercise
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sedentary control
Number of subjects: 16
Study: 22819205

Group type: EXPERIMENTAL
Intervention: Supportive care plus SSRI
Number of subjects: 220

Group type: COMPARATOR
Intervention: Supportive care
Number of subjects: 220
Study: 21946897

Group type: EXPERIMENTAL
Intervention: CRS7 high risk (n=440)
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: CRS7 medium risk (n=310)
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: CRS7 low risk (n=188)
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: CRS7 high risk
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: CRS7
Number of subjects: 938
Study: 19216762

Group type: EXPERIMENTAL
Intervention: Interventions implemented in workplaces
Number of subjects: 0
Study: 17682247

Group type: COMPARATOR
Intervention: Feedback tip sheet only
Number of subjects: 10144

Group type: COMPARATOR
Intervention: Tip sheet plus Rate Your Plate (RYP)
Number of subjects: 10144

Group type: COMPARATOR
Intervention: Tip sheet, RYP, plus Let's Eat Kit (LEK)
Number of subjects: 10144

Group type: COMPARATOR
Intervention: All written materials plus CD audio intervention (AUD)
Number of subjects: 10144

Group type: EXPERIMENTAL
Intervention: All written materials plus counseling from a trained lay person (LAY-C)
Number of subjects: 10144

Group type: EXPERIMENTAL
Intervention: All written materials plus counseling by a nutritionist (NUT-C)
Number of subjects: 10144

Group type: COMPARATOR
Intervention: Total sample
Number of subjects: 10144

Group type: COMPARATOR
Intervention: Participants with borderline-high BC levels
Number of subjects: 10144

Group type: COMPARATOR
Intervention: Participants with high BC levels
Number of subjects: 10144

Group type: EXPERIMENTAL
Intervention: Hispanic participants in the audio condition
Number of subjects: 10144
Study: 12562958

Group type: COMPARATOR
Intervention: Postmenopausal no-HRT
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Postmenopausal HRT
Number of subjects: 103
Study: 11686653

Group type: EXPERIMENTAL
Intervention: Clock Drawing Test scoring systems (Freedman et al., 1994; Libon et al., 1996; Rouleau et al., 1992)
Number of subjects: 20
Study: 9481276

Group type: EXPERIMENTAL
Intervention: Normal saline (NS) instillation during endotracheal suctioning
Number of subjects: 25

Group type: COMPARATOR
Intervention: No instillation of normal saline during endotracheal suctioning
Number of subjects: 25
Study: 8323889

Group type: EXPERIMENTAL
Intervention: 25-gauge Whitacre needle
Number of subjects: 400

Group type: COMPARATOR
Intervention: 25-gauge Quincke needle
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 400
Study: 3552360

Group type: EXPERIMENTAL
Intervention: Fluradoline, 300 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin, 650 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluradoline, 150 mg
Number of subjects: 0
Study: 29429534

Group type: EXPERIMENTAL
Intervention: Parboiled rice (PBR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: White rice (WR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brown rice (BR)
Number of subjects: 0
Study: 26804788

Group type: EXPERIMENTAL
Intervention: High-SR writing task followed by high-SR voice task
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Low-SR writing task followed by high-SR voice task
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: High-SR writing task followed by relaxation intervention and high-SR voice task
Number of subjects: 104
Study: 24929459

Group type: EXPERIMENTAL
Intervention: Acupoint injection of phylloquinone (vitamin K1) in SP6
Number of subjects: 4
Study: 22587416

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy plus concurrent chemoradiotherapy (69 patients)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Aurora-A and HIF-1α co-overexpression
Number of subjects: 144
Study: 20234166

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 17380190

Group type: EXPERIMENTAL
Intervention: Acute multidisciplinary group intervention (four 1.5-hour sessions)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group (standard medical care)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Acute multidisciplinary group intervention
Number of subjects: 127
Study: 15618067

Group type: EXPERIMENTAL
Intervention: Fibrinolysis
Number of subjects: 1462

Group type: COMPARATOR
Intervention: Primary PCI
Number of subjects: 1462
Study: 12000208

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 40
Study: 9928561

Group type: EXPERIMENTAL
Intervention: Primary endocrine therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant endocrine therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Faslodex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Arimidex
Number of subjects: 0
Study: 7706955

Group type: EXPERIMENTAL
Intervention: Phasic exercises and chiropractic therapy (Group 2, n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard exercises (stretching/isometric/isokinetic) and chiropractic therapy (Group 1, n = 15)
Number of subjects: 30
Study: 2533024

Group type: EXPERIMENTAL
Intervention: Flunoxaprofen 400 mg/day p.o. for 30 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Naproxen 500 mg/day p.o. for 30 days
Number of subjects: 20
Study: 1266667

Group type: EXPERIMENTAL
Intervention: 500 mug digoxin
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 30 mg pentazocine
Number of subjects: 39

Group type: COMPARATOR
Intervention: bumetanide
Number of subjects: 39

Group type: COMPARATOR
Intervention: isotonic sodium chloride
Number of subjects: 39
Study: 31811645

Group type: EXPERIMENTAL
Intervention: DPBM with adjunctive use of EMD (test group, n = 20)
Number of subjects: 42

Group type: COMPARATOR
Intervention: DPBM without EMD (control group, n = 22)
Number of subjects: 42